Suppr超能文献

相似文献

2
The landscape of the mesenchymal signature in brain tumours.
Brain. 2019 Apr 1;142(4):847-866. doi: 10.1093/brain/awz044.
5
Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Oncotarget. 2015 Jun 20;6(17):15077-94. doi: 10.18632/oncotarget.3730.
6
Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.
Sci Rep. 2017 Dec 14;7(1):17556. doi: 10.1038/s41598-017-17752-w.
8
SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma.
Oncogene. 2021 Aug;40(32):5066-5080. doi: 10.1038/s41388-021-01825-2. Epub 2021 May 21.
9
Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
EBioMedicine. 2019 May;43:159-170. doi: 10.1016/j.ebiom.2019.04.002. Epub 2019 Apr 12.
10
Immune Microenvironment in Glioblastoma Subtypes.
Front Immunol. 2018 May 8;9:1004. doi: 10.3389/fimmu.2018.01004. eCollection 2018.

引用本文的文献

1
Rewiring of cortical glucose metabolism fuels human brain cancer growth.
Nature. 2025 Sep 3. doi: 10.1038/s41586-025-09460-7.
3
Progenitor cells, microglia, and non-coding RNAs: Orchestrators of glioblastoma pathogenesis and therapeutic resistance.
Noncoding RNA Res. 2025 Aug 5;15:85-99. doi: 10.1016/j.ncrna.2025.07.007. eCollection 2025 Dec.
4
An engineered glioblastoma model yields macrophage-secreted drivers of invasion.
JCI Insight. 2025 Aug 22;10(16). doi: 10.1172/jci.insight.181903.
7
Harnessing innate immunity against glioblastoma microenvironment.
Front Immunol. 2025 Jul 25;16:1648601. doi: 10.3389/fimmu.2025.1648601. eCollection 2025.

本文引用的文献

1
Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
Nat Genet. 2017 Apr;49(4):594-599. doi: 10.1038/ng.3806. Epub 2017 Mar 6.
2
GlioVis data portal for visualization and analysis of brain tumor expression datasets.
Neuro Oncol. 2017 Jan;19(1):139-141. doi: 10.1093/neuonc/now247. Epub 2016 Nov 9.
3
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.
Cell. 2016 Nov 17;167(5):1281-1295.e18. doi: 10.1016/j.cell.2016.10.039.
4
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.
Cancer Discov. 2016 Nov;6(11):1230-1236. doi: 10.1158/2159-8290.CD-16-0575. Epub 2016 Sep 28.
6
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.
Science. 2016 May 20;352(6288):aad3018. doi: 10.1126/science.aad3018.
7
CANCER IMMUNOLOGY. The "cancer immunogram".
Science. 2016 May 6;352(6286):658-60. doi: 10.1126/science.aaf2834.
8
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
J Clin Oncol. 2016 Jul 1;34(19):2206-11. doi: 10.1200/JCO.2016.66.6552. Epub 2016 Mar 21.
9
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
JCI Insight. 2016;1(2). doi: 10.1172/jci.insight.85841. Epub 2016 Feb 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验